 Laurel Lenz
Concepts (331)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Listeria monocytogenes | 30 | 2021 | 126 | 7.250 |
Why?
| | Listeriosis | 20 | 2021 | 70 | 5.110 |
Why?
| | Killer Cells, Natural | 12 | 2021 | 443 | 3.010 |
Why?
| | Interferon-gamma | 12 | 2019 | 789 | 2.370 |
Why?
| | Interleukin-10 | 5 | 2021 | 302 | 2.220 |
Why?
| | Receptors, Interferon | 8 | 2019 | 52 | 2.000 |
Why?
| | Myeloid Cells | 5 | 2020 | 148 | 1.940 |
Why?
| | Interferon Type I | 7 | 2019 | 141 | 1.590 |
Why?
| | Macrophages | 12 | 2020 | 1544 | 1.430 |
Why?
| | Interleukin-18 | 4 | 2018 | 236 | 1.260 |
Why?
| | Streptococcus pneumoniae | 2 | 2020 | 169 | 1.160 |
Why?
| | Dendritic Cells | 9 | 2018 | 484 | 1.100 |
Why?
| | Immunity, Innate | 12 | 2021 | 825 | 1.050 |
Why?
| | Bacterial Proteins | 9 | 2018 | 873 | 0.980 |
Why?
| | Bacterial Infections | 4 | 2018 | 250 | 0.980 |
Why?
| | Interferon-beta | 3 | 2018 | 92 | 0.980 |
Why?
| | Host-Pathogen Interactions | 3 | 2020 | 363 | 0.880 |
Why?
| | Interferon-alpha | 2 | 2018 | 198 | 0.840 |
Why?
| | Mice, Inbred C57BL | 21 | 2021 | 5750 | 0.800 |
Why?
| | Animals | 52 | 2022 | 36850 | 0.800 |
Why?
| | Repressor Proteins | 2 | 2018 | 427 | 0.780 |
Why?
| | Mice | 41 | 2022 | 17759 | 0.770 |
Why?
| | STAT3 Transcription Factor | 3 | 2022 | 206 | 0.760 |
Why?
| | Mice, Knockout | 15 | 2021 | 3009 | 0.750 |
Why?
| | Leukocytes, Mononuclear | 2 | 2025 | 558 | 0.710 |
Why?
| | Interleukin-15 | 2 | 2019 | 97 | 0.700 |
Why?
| | Casein Kinase II | 1 | 2020 | 21 | 0.700 |
Why?
| | Pneumonia, Pneumococcal | 1 | 2020 | 48 | 0.630 |
Why?
| | N-Acetylmuramoyl-L-alanine Amidase | 3 | 2009 | 5 | 0.630 |
Why?
| | Radiation Injuries | 2 | 2011 | 145 | 0.630 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 2 | 2018 | 151 | 0.620 |
Why?
| | Orthomyxoviridae Infections | 1 | 2020 | 76 | 0.620 |
Why?
| | Influenza A virus | 1 | 2020 | 110 | 0.610 |
Why?
| | Lymphocyte Activation | 4 | 2016 | 1150 | 0.610 |
Why?
| | Bacteria | 3 | 2018 | 854 | 0.600 |
Why?
| | Pneumococcal Infections | 1 | 2020 | 115 | 0.600 |
Why?
| | Coinfection | 1 | 2020 | 137 | 0.590 |
Why?
| | Basic-Leucine Zipper Transcription Factors | 1 | 2018 | 41 | 0.580 |
Why?
| | Streptococcal Infections | 1 | 2020 | 151 | 0.580 |
Why?
| | Macrophage Activation | 4 | 2017 | 201 | 0.570 |
Why?
| | Disease Susceptibility | 4 | 2021 | 345 | 0.530 |
Why?
| | Flow Cytometry | 4 | 2016 | 1180 | 0.480 |
Why?
| | Pneumonia | 1 | 2021 | 635 | 0.470 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 368 | 0.460 |
Why?
| | Bacterial Vaccines | 2 | 2020 | 63 | 0.450 |
Why?
| | Adenosine Triphosphatases | 3 | 2007 | 165 | 0.440 |
Why?
| | T-Lymphocytes, Cytotoxic | 6 | 2007 | 173 | 0.440 |
Why?
| | Argon Plasma Coagulation | 2 | 2011 | 6 | 0.430 |
Why?
| | Early Growth Response Protein 3 | 1 | 2013 | 1 | 0.430 |
Why?
| | Influenza, Human | 1 | 2020 | 618 | 0.420 |
Why?
| | Lung Diseases | 1 | 2020 | 768 | 0.420 |
Why?
| | Interferon Regulatory Factor-3 | 3 | 2011 | 16 | 0.410 |
Why?
| | Radiotherapy | 2 | 2011 | 201 | 0.410 |
Why?
| | Antigens, Bacterial | 4 | 1998 | 129 | 0.400 |
Why?
| | Toll-Like Receptors | 3 | 2012 | 185 | 0.390 |
Why?
| | Gene Silencing | 1 | 2013 | 195 | 0.390 |
Why?
| | H-2 Antigens | 3 | 1997 | 115 | 0.390 |
Why?
| | Anthrax | 1 | 2012 | 9 | 0.390 |
Why?
| | Bacillus anthracis | 1 | 2012 | 13 | 0.380 |
Why?
| | Gene Expression | 3 | 2019 | 1500 | 0.380 |
Why?
| | Lymph Nodes | 2 | 2012 | 492 | 0.370 |
Why?
| | Membrane Transport Proteins | 2 | 2003 | 162 | 0.370 |
Why?
| | Telangiectasis | 1 | 2011 | 7 | 0.360 |
Why?
| | Sigmoid Diseases | 1 | 2011 | 12 | 0.360 |
Why?
| | Membrane Proteins | 5 | 2021 | 1163 | 0.360 |
Why?
| | Rectal Diseases | 1 | 2011 | 23 | 0.360 |
Why?
| | Cyclic GMP | 1 | 2011 | 93 | 0.360 |
Why?
| | Peptidoglycan | 2 | 2009 | 23 | 0.360 |
Why?
| | Lung | 3 | 2019 | 4063 | 0.360 |
Why?
| | Inflammasomes | 1 | 2012 | 128 | 0.350 |
Why?
| | Electrocoagulation | 1 | 2011 | 40 | 0.350 |
Why?
| | Escherichia coli Proteins | 2 | 2003 | 194 | 0.350 |
Why?
| | Cyclic AMP | 1 | 2011 | 234 | 0.340 |
Why?
| | Proctocolitis | 1 | 2010 | 1 | 0.340 |
Why?
| | Interleukin-1beta | 1 | 2012 | 371 | 0.340 |
Why?
| | Gastrointestinal Hemorrhage | 1 | 2011 | 132 | 0.330 |
Why?
| | Cells, Cultured | 6 | 2019 | 4192 | 0.330 |
Why?
| | Recombinant Proteins | 3 | 2011 | 1350 | 0.320 |
Why?
| | Down-Regulation | 5 | 2019 | 656 | 0.320 |
Why?
| | Antigens | 1 | 2011 | 358 | 0.310 |
Why?
| | CD5 Antigens | 1 | 2009 | 10 | 0.310 |
Why?
| | Mice, Transgenic | 5 | 2021 | 2163 | 0.300 |
Why?
| | Mice, Inbred BALB C | 9 | 2012 | 1269 | 0.300 |
Why?
| | Intubation, Intratracheal | 1 | 2011 | 257 | 0.300 |
Why?
| | Bone Marrow Cells | 3 | 2010 | 316 | 0.290 |
Why?
| | Cell Communication | 1 | 2010 | 315 | 0.290 |
Why?
| | Lymphocytes | 2 | 2014 | 393 | 0.280 |
Why?
| | Bacteremia | 1 | 2010 | 212 | 0.280 |
Why?
| | Recombination, Genetic | 1 | 2008 | 200 | 0.270 |
Why?
| | Genetic Vectors | 1 | 2008 | 317 | 0.270 |
Why?
| | Antigen Presentation | 3 | 1998 | 216 | 0.270 |
Why?
| | Nitric Oxide | 1 | 2012 | 915 | 0.260 |
Why?
| | Genes, Bacterial | 2 | 2008 | 164 | 0.260 |
Why?
| | Lipopolysaccharides | 3 | 2021 | 886 | 0.260 |
Why?
| | Host-Parasite Interactions | 1 | 2007 | 114 | 0.260 |
Why?
| | B-Lymphocytes | 1 | 2012 | 846 | 0.260 |
Why?
| | Selection, Genetic | 1 | 2008 | 264 | 0.250 |
Why?
| | Coculture Techniques | 3 | 2025 | 239 | 0.250 |
Why?
| | Head and Neck Neoplasms | 2 | 2021 | 604 | 0.250 |
Why?
| | Female | 19 | 2021 | 72816 | 0.240 |
Why?
| | Communicable Diseases | 1 | 2007 | 159 | 0.240 |
Why?
| | Virulence | 5 | 2008 | 266 | 0.240 |
Why?
| | Respiratory Syncytial Viruses | 1 | 2025 | 52 | 0.230 |
Why?
| | Cytokines | 6 | 2025 | 2084 | 0.230 |
Why?
| | Epitopes | 2 | 1997 | 480 | 0.230 |
Why?
| | Inflammation | 3 | 2020 | 2835 | 0.220 |
Why?
| | Respiratory Syncytial Virus, Human | 1 | 2025 | 74 | 0.220 |
Why?
| | Cytotoxicity, Immunologic | 3 | 2003 | 225 | 0.210 |
Why?
| | Respiratory Syncytial Virus Infections | 1 | 2025 | 127 | 0.210 |
Why?
| | Male | 13 | 2025 | 67330 | 0.200 |
Why?
| | Cell Line | 5 | 2012 | 2838 | 0.200 |
Why?
| | Radioimmunotherapy | 1 | 2021 | 16 | 0.180 |
Why?
| | Humans | 22 | 2025 | 136803 | 0.180 |
Why?
| | Disease Models, Animal | 3 | 2020 | 4282 | 0.180 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2016 | 851 | 0.180 |
Why?
| | Ligands | 4 | 2019 | 661 | 0.180 |
Why?
| | Mouth Diseases | 1 | 2021 | 45 | 0.170 |
Why?
| | Vaccinia | 1 | 2000 | 21 | 0.170 |
Why?
| | Lymphocytic Choriomeningitis | 1 | 2000 | 14 | 0.170 |
Why?
| | Respiratory Tract Infections | 1 | 2025 | 394 | 0.170 |
Why?
| | Transcription, Genetic | 2 | 2019 | 1455 | 0.170 |
Why?
| | Antigen-Presenting Cells | 1 | 2000 | 156 | 0.170 |
Why?
| | Legionnaires' Disease | 1 | 2019 | 4 | 0.160 |
Why?
| | Legionella pneumophila | 1 | 2019 | 3 | 0.160 |
Why?
| | Bites and Stings | 1 | 2020 | 32 | 0.160 |
Why?
| | Malaria, Cerebral | 1 | 2019 | 4 | 0.160 |
Why?
| | Amino Acid Sequence | 6 | 2009 | 2138 | 0.160 |
Why?
| | CD4 Antigens | 1 | 2019 | 142 | 0.150 |
Why?
| | Signal Transduction | 6 | 2019 | 5077 | 0.150 |
Why?
| | STAT4 Transcription Factor | 1 | 2018 | 4 | 0.150 |
Why?
| | Carcinoma, Pancreatic Ductal | 1 | 2022 | 287 | 0.150 |
Why?
| | Enhancer Elements, Genetic | 1 | 2019 | 190 | 0.140 |
Why?
| | Solubility | 1 | 2018 | 245 | 0.140 |
Why?
| | Disease Progression | 2 | 2022 | 2751 | 0.130 |
Why?
| | Interleukin-2 | 1 | 2018 | 455 | 0.130 |
Why?
| | Monocytes | 1 | 2019 | 563 | 0.130 |
Why?
| | Macrophages, Alveolar | 1 | 2019 | 391 | 0.130 |
Why?
| | Blotting, Western | 2 | 2013 | 1225 | 0.130 |
Why?
| | Survival Analysis | 1 | 2019 | 1321 | 0.130 |
Why?
| | NF-kappa B | 1 | 2019 | 691 | 0.120 |
Why?
| | Adoptive Transfer | 1 | 2016 | 224 | 0.120 |
Why?
| | Chromatin | 1 | 2019 | 519 | 0.120 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2018 | 279 | 0.120 |
Why?
| | Phosphorylation | 2 | 2010 | 1758 | 0.120 |
Why?
| | Adenocarcinoma | 1 | 2022 | 938 | 0.110 |
Why?
| | Breeding | 1 | 2014 | 63 | 0.110 |
Why?
| | Genotype | 1 | 2020 | 1914 | 0.110 |
Why?
| | Chronic Disease | 2 | 2011 | 1786 | 0.110 |
Why?
| | Housing, Animal | 1 | 2014 | 46 | 0.110 |
Why?
| | Pancreatic Neoplasms | 1 | 2022 | 935 | 0.110 |
Why?
| | Antibodies, Monoclonal, Murine-Derived | 1 | 2013 | 86 | 0.100 |
Why?
| | SEC Translocation Channels | 2 | 2003 | 10 | 0.100 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2013 | 138 | 0.100 |
Why?
| | T-Lymphocyte Subsets | 2 | 2007 | 425 | 0.100 |
Why?
| | Caspases, Initiator | 1 | 2012 | 17 | 0.100 |
Why?
| | Interleukin-12 | 3 | 2011 | 121 | 0.100 |
Why?
| | Molecular Sequence Data | 5 | 2004 | 2894 | 0.100 |
Why?
| | Infant | 3 | 2025 | 9395 | 0.100 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2013 | 346 | 0.100 |
Why?
| | Spores, Bacterial | 1 | 2012 | 19 | 0.100 |
Why?
| | Reactive Oxygen Species | 2 | 2012 | 621 | 0.100 |
Why?
| | Receptors, CCR7 | 1 | 2012 | 32 | 0.100 |
Why?
| | Phagosomes | 1 | 2012 | 44 | 0.100 |
Why?
| | Myeloid Differentiation Factor 88 | 2 | 2010 | 99 | 0.090 |
Why?
| | Caspase 1 | 1 | 2012 | 143 | 0.090 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2012 | 173 | 0.090 |
Why?
| | Lymphocyte Depletion | 1 | 2012 | 135 | 0.090 |
Why?
| | Receptors, Complement | 1 | 2012 | 122 | 0.090 |
Why?
| | Aged | 4 | 2020 | 23808 | 0.090 |
Why?
| | Immunologic Factors | 1 | 2013 | 236 | 0.090 |
Why?
| | Instillation, Drug | 1 | 2011 | 10 | 0.090 |
Why?
| | Caspases | 1 | 2012 | 247 | 0.090 |
Why?
| | Receptors, Antigen, B-Cell | 1 | 2012 | 130 | 0.090 |
Why?
| | Colon, Sigmoid | 1 | 2011 | 20 | 0.090 |
Why?
| | Francisella tularensis | 1 | 2011 | 32 | 0.090 |
Why?
| | Intention to Treat Analysis | 1 | 2011 | 73 | 0.090 |
Why?
| | Vesiculovirus | 1 | 2011 | 16 | 0.090 |
Why?
| | Adaptive Immunity | 1 | 2012 | 165 | 0.090 |
Why?
| | Immunotherapy | 1 | 2016 | 640 | 0.090 |
Why?
| | Cell Death | 1 | 2012 | 372 | 0.090 |
Why?
| | Phagocytes | 1 | 2011 | 100 | 0.090 |
Why?
| | TRPM Cation Channels | 1 | 2011 | 74 | 0.090 |
Why?
| | Gastrointestinal Microbiome | 1 | 2018 | 698 | 0.090 |
Why?
| | Immunoglobulin M | 1 | 2012 | 289 | 0.090 |
Why?
| | STAT1 Transcription Factor | 1 | 2010 | 73 | 0.080 |
Why?
| | Melanoma, Experimental | 1 | 2011 | 114 | 0.080 |
Why?
| | Immunologic Memory | 2 | 2007 | 370 | 0.080 |
Why?
| | Histocompatibility Antigens Class I | 2 | 2003 | 202 | 0.080 |
Why?
| | Toll-Like Receptor 2 | 2 | 2007 | 115 | 0.080 |
Why?
| | Rectum | 1 | 2011 | 185 | 0.080 |
Why?
| | Base Sequence | 4 | 2004 | 2179 | 0.080 |
Why?
| | Gene Deletion | 2 | 2008 | 389 | 0.080 |
Why?
| | Receptors, Cell Surface | 2 | 2009 | 382 | 0.080 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 975 | 0.080 |
Why?
| | Spleen | 2 | 2008 | 514 | 0.080 |
Why?
| | T-Lymphocytes, Regulatory | 2 | 2022 | 387 | 0.080 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2010 | 368 | 0.080 |
Why?
| | Mycobacterium Infections, Nontuberculous | 1 | 2013 | 360 | 0.080 |
Why?
| | Alanine Racemase | 1 | 2008 | 2 | 0.080 |
Why?
| | Glutamate-Ammonia Ligase | 1 | 2008 | 7 | 0.070 |
Why?
| | Endometrial Neoplasms | 1 | 2011 | 199 | 0.070 |
Why?
| | Genetic Complementation Test | 1 | 2008 | 66 | 0.070 |
Why?
| | Aged, 80 and over | 2 | 2011 | 7593 | 0.070 |
Why?
| | AIDS Vaccines | 1 | 2008 | 52 | 0.070 |
Why?
| | Carrier Proteins | 1 | 2012 | 769 | 0.070 |
Why?
| | Uterine Cervical Neoplasms | 1 | 2011 | 254 | 0.070 |
Why?
| | CD8-Positive T-Lymphocytes | 4 | 2008 | 913 | 0.070 |
Why?
| | Group IV Phospholipases A2 | 1 | 2007 | 47 | 0.070 |
Why?
| | Vaccines, Attenuated | 1 | 2008 | 131 | 0.070 |
Why?
| | Hemolysin Proteins | 1 | 2007 | 34 | 0.070 |
Why?
| | Macrophages, Peritoneal | 1 | 2007 | 94 | 0.070 |
Why?
| | Liver | 3 | 2018 | 1940 | 0.070 |
Why?
| | Mutation | 4 | 2010 | 3947 | 0.070 |
Why?
| | Tumor Microenvironment | 2 | 2021 | 672 | 0.070 |
Why?
| | Immunotherapy, Adoptive | 1 | 2011 | 321 | 0.070 |
Why?
| | Plasmids | 1 | 2008 | 360 | 0.070 |
Why?
| | Bacterial Toxins | 1 | 2007 | 105 | 0.070 |
Why?
| | Bystander Effect | 1 | 2007 | 16 | 0.070 |
Why?
| | Heat-Shock Proteins | 1 | 2007 | 142 | 0.070 |
Why?
| | Biological Transport | 1 | 2007 | 416 | 0.060 |
Why?
| | Fungi | 1 | 2007 | 144 | 0.060 |
Why?
| | Protein Structure, Tertiary | 1 | 2009 | 860 | 0.060 |
Why?
| | Virulence Factors | 1 | 2007 | 166 | 0.060 |
Why?
| | Autoantibodies | 1 | 2013 | 1496 | 0.060 |
Why?
| | Antibodies | 1 | 2007 | 411 | 0.060 |
Why?
| | Obesity | 1 | 2018 | 2982 | 0.060 |
Why?
| | Alleles | 2 | 2020 | 890 | 0.060 |
Why?
| | Antigens, CD1 | 1 | 2005 | 58 | 0.060 |
Why?
| | A549 Cells | 1 | 2025 | 66 | 0.060 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2007 | 324 | 0.060 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 2004 | 164 | 0.050 |
Why?
| | CD4-Positive T-Lymphocytes | 2 | 2007 | 1095 | 0.050 |
Why?
| | Autolysis | 1 | 2003 | 3 | 0.050 |
Why?
| | Prostatic Neoplasms | 1 | 2011 | 1034 | 0.050 |
Why?
| | Gene Expression Profiling | 1 | 2010 | 1772 | 0.050 |
Why?
| | Severity of Illness Index | 1 | 2011 | 2822 | 0.050 |
Why?
| | Immunity, Cellular | 1 | 2025 | 268 | 0.050 |
Why?
| | Interleukin-6 | 1 | 2007 | 778 | 0.050 |
Why?
| | Adult | 3 | 2025 | 37643 | 0.050 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2002 | 385 | 0.050 |
Why?
| | DNA Primers | 1 | 2002 | 514 | 0.040 |
Why?
| | Cloning, Molecular | 1 | 2002 | 534 | 0.040 |
Why?
| | T-Lymphocytes | 2 | 2007 | 1993 | 0.040 |
Why?
| | Nucleoproteins | 1 | 2000 | 29 | 0.040 |
Why?
| | Chimera | 1 | 2000 | 58 | 0.040 |
Why?
| | Neoplasms | 1 | 2016 | 2643 | 0.040 |
Why?
| | Lymphocytic choriomeningitis virus | 1 | 2000 | 24 | 0.040 |
Why?
| | Vaccinia virus | 1 | 2000 | 43 | 0.040 |
Why?
| | Cell Movement | 1 | 2005 | 968 | 0.040 |
Why?
| | Nucleotides, Cyclic | 1 | 2020 | 17 | 0.040 |
Why?
| | Gene Knock-In Techniques | 1 | 2020 | 56 | 0.040 |
Why?
| | Major Histocompatibility Complex | 1 | 2000 | 227 | 0.040 |
Why?
| | Fibroblasts | 1 | 2025 | 993 | 0.040 |
Why?
| | Middle Aged | 2 | 2011 | 33239 | 0.040 |
Why?
| | Germ-Free Life | 1 | 2018 | 34 | 0.040 |
Why?
| | Fatty Acids, Volatile | 1 | 2018 | 56 | 0.040 |
Why?
| | Diet, Western | 1 | 2018 | 81 | 0.040 |
Why?
| | Prospective Studies | 1 | 2010 | 7573 | 0.030 |
Why?
| | Phenotype | 2 | 2005 | 3189 | 0.030 |
Why?
| | Bile Acids and Salts | 1 | 2018 | 200 | 0.030 |
Why?
| | Dysbiosis | 1 | 2018 | 181 | 0.030 |
Why?
| | Polymorphism, Genetic | 1 | 2020 | 659 | 0.030 |
Why?
| | Transformation, Bacterial | 1 | 1996 | 8 | 0.030 |
Why?
| | Proteomics | 1 | 2003 | 1109 | 0.030 |
Why?
| | Treatment Outcome | 1 | 2011 | 10748 | 0.030 |
Why?
| | Gene Library | 1 | 1996 | 116 | 0.030 |
Why?
| | Feces | 1 | 2018 | 481 | 0.030 |
Why?
| | Pregnancy | 2 | 2018 | 6729 | 0.030 |
Why?
| | Adiposity | 1 | 2018 | 518 | 0.030 |
Why?
| | Infant, Newborn | 1 | 2025 | 6032 | 0.030 |
Why?
| | Intestinal Mucosa | 1 | 2018 | 621 | 0.030 |
Why?
| | Rituximab | 1 | 2013 | 176 | 0.020 |
Why?
| | Parrots | 1 | 1992 | 1 | 0.020 |
Why?
| | Polyomaviridae | 1 | 1992 | 1 | 0.020 |
Why?
| | Guidelines as Topic | 1 | 2014 | 276 | 0.020 |
Why?
| | Bird Diseases | 1 | 1992 | 12 | 0.020 |
Why?
| | Mothers | 1 | 2018 | 752 | 0.020 |
Why?
| | Capsid | 1 | 1992 | 93 | 0.020 |
Why?
| | Interleukin-12 Receptor beta 2 Subunit | 1 | 2011 | 1 | 0.020 |
Why?
| | Papillomaviridae | 1 | 1992 | 126 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2007 | 1242 | 0.020 |
Why?
| | Dimerization | 1 | 2010 | 198 | 0.020 |
Why?
| | Disulfides | 1 | 2010 | 107 | 0.020 |
Why?
| | Body Weight | 1 | 2014 | 985 | 0.020 |
Why?
| | Genes, Reporter | 1 | 2010 | 268 | 0.020 |
Why?
| | Child, Preschool | 1 | 2025 | 10997 | 0.020 |
Why?
| | Adjuvants, Immunologic | 1 | 2011 | 226 | 0.020 |
Why?
| | Cysteine | 1 | 2010 | 204 | 0.020 |
Why?
| | Cancer Vaccines | 1 | 2011 | 172 | 0.020 |
Why?
| | Autoimmunity | 1 | 2014 | 908 | 0.020 |
Why?
| | Antibodies, Viral | 1 | 1992 | 624 | 0.020 |
Why?
| | Indomethacin | 1 | 2007 | 81 | 0.020 |
Why?
| | Mice, Inbred ICR | 1 | 2007 | 119 | 0.020 |
Why?
| | Cyclooxygenase Inhibitors | 1 | 2007 | 79 | 0.020 |
Why?
| | Arachidonic Acids | 1 | 2007 | 62 | 0.020 |
Why?
| | Cyclooxygenase 2 | 1 | 2007 | 178 | 0.020 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2007 | 171 | 0.020 |
Why?
| | Cytosol | 1 | 2007 | 226 | 0.020 |
Why?
| | Enzyme Activation | 1 | 2007 | 810 | 0.020 |
Why?
| | Calcium Signaling | 1 | 2007 | 249 | 0.020 |
Why?
| | MAP Kinase Signaling System | 1 | 2007 | 320 | 0.020 |
Why?
| | Neutrophils | 1 | 2011 | 1236 | 0.010 |
Why?
| | Adolescent | 1 | 2025 | 21385 | 0.010 |
Why?
| | Antigens, CD1d | 1 | 2005 | 68 | 0.010 |
Why?
| | Antibodies, Monoclonal | 1 | 1992 | 1430 | 0.010 |
Why?
| | Muromegalovirus | 1 | 2004 | 23 | 0.010 |
Why?
| | Mycobacterium bovis | 1 | 2004 | 16 | 0.010 |
Why?
| | Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2004 | 30 | 0.010 |
Why?
| | Child | 1 | 2025 | 21819 | 0.010 |
Why?
| | TNF-Related Apoptosis-Inducing Ligand | 1 | 2004 | 51 | 0.010 |
Why?
| | Interleukin-4 | 1 | 2005 | 216 | 0.010 |
Why?
| | Mast-Cell Sarcoma | 1 | 2003 | 6 | 0.010 |
Why?
| | Immunodominant Epitopes | 1 | 2003 | 28 | 0.010 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2004 | 188 | 0.010 |
Why?
| | Injections, Intravenous | 1 | 2003 | 207 | 0.010 |
Why?
| | Herpesviridae Infections | 1 | 2004 | 149 | 0.010 |
Why?
| | Clone Cells | 1 | 2003 | 266 | 0.010 |
Why?
| | Sequence Deletion | 1 | 2003 | 183 | 0.010 |
Why?
| | Epitopes, T-Lymphocyte | 1 | 2003 | 187 | 0.010 |
Why?
| | Membrane Glycoproteins | 1 | 2004 | 500 | 0.010 |
Why?
| | Calcium | 1 | 2007 | 1197 | 0.010 |
Why?
| | Microfilament Proteins | 1 | 2001 | 131 | 0.010 |
Why?
| | Cell Adhesion Molecules | 1 | 2001 | 181 | 0.010 |
Why?
| | Phosphoproteins | 1 | 2001 | 337 | 0.010 |
Why?
| | Mice, Inbred DBA | 1 | 1998 | 200 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2003 | 3406 | 0.010 |
Why?
| | Time Factors | 1 | 2004 | 6809 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2001 | 3265 | 0.010 |
Why?
| | Chick Embryo | 1 | 1992 | 130 | 0.010 |
Why?
| | Peptides | 1 | 1998 | 981 | 0.010 |
Why?
| | Hybridomas | 1 | 1992 | 237 | 0.010 |
Why?
|
|
Lenz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|